Individualizing the treatment of gout

Cleveland Clinic Journal of Medicine

Volumn 63, Issue 3, 1996, Pages 150-155

  George, Teresa M ^a   Mandell, Brian F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANALGESIC AGENT; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; FENOPROFEN; IBUPROFEN; INDOMETACIN; KETOROLAC; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SULINDAC; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; GOUT; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION;

EID: 0029996752     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.63.3.150     Document Type: Article

References (16)

1. Roubenoff R. Gout and hyperuricemia. Rheum Dis Clin North Am 1990; 16:539-550.
2. Davson DA, Adams PF. Current estimates from the National Health Interview Survey, United States, 1986. Vital and Health Statistics, series 10. Washington DC: US Government Printing Office; 1987.
3. Rodnan G. Treatment of gout and other forms of crystal-induced arthritis. Bull Rheum Dis 1982; 32:77-87.
4. Ahem MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med 1987; 17:301-304.
5. Wallace SL, Singer JZ. Review: systemic toxicity associated with the intravenous administration of colchicine - guidelines for use. J Rheumatol 1988; 15:495-499.
6. Roberts WN, Liang MH, Stern SH. Colchicine in acute gout. Reassessment of risks and benefits. JAMA 1987; 257:1920-1922.
7. Putterman C, Ben-Chetrit E, Caraco Y, Levy M. Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin Arthritis Rheum 1991; 21:143-155.
8. Gray RG, Tenebaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981; 10:231-254.
9. Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol 1993; 20:111-113.
10. Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the Literature. Semin Arthritis Rheum 1990; 19:329-336
11. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988; 31:803-805.
12. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21:1325-1327.
13. Yu T. The efficacy of colchicine prophylaxis in articular gout - a reappraisal after 20 years. Semin Arthritis Rheum 1982; 12:256-264.
14. Paulus HE, Schlosstein LH, Godfrey RG, Klinenberg JR, Bluestone R. Prophylactic colchicine therapy of intercritical gout: a placebo controlled study of probenecid treated patients. Arthritis Rheum 1974; 17:609-614.
15. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med 1987; 316:1562-1568.
16. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency Am J Med 1984; 76:47-56.